A multicentre, randomised, double blind, parallel group study to compare the efficacy and safety of salmeterol/fluticasone propionate combination Product (Seretide) 50/100mcg with fluticasone propionate (Flixotide) 200mcg, both delivered twice daily via the DISKUS inhaler, in the treatment of children aged 6−12 years with symptomatic asthma.
Latest Information Update: 17 Jul 2023
Price :
$35 *
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Acronyms COMBO
- Sponsors GlaxoSmithKline; GSK
- 22 Sep 2010 Results were presented at the 20th Annual Congress of the European Respiratory Society.
- 01 Apr 2009 Actual end date (Oct 2008) added, Planned number of patients changed from 200 to 176 as reported by ClinicalTrials.gov.
- 01 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.